1. Home
  2. HCTI vs VRAX Comparison

HCTI vs VRAX Comparison

Compare HCTI & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCTI
  • VRAX
  • Stock Information
  • Founded
  • HCTI 2020
  • VRAX 2013
  • Country
  • HCTI United States
  • VRAX United Kingdom
  • Employees
  • HCTI N/A
  • VRAX N/A
  • Industry
  • HCTI Retail: Computer Software & Peripheral Equipment
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HCTI Technology
  • VRAX Health Care
  • Exchange
  • HCTI Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • HCTI 6.8M
  • VRAX 7.8M
  • IPO Year
  • HCTI 2021
  • VRAX 2022
  • Fundamental
  • Price
  • HCTI $0.83
  • VRAX $2.06
  • Analyst Decision
  • HCTI
  • VRAX
  • Analyst Count
  • HCTI 0
  • VRAX 0
  • Target Price
  • HCTI N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • HCTI 316.5K
  • VRAX 117.4K
  • Earning Date
  • HCTI 11-14-2024
  • VRAX 02-05-2025
  • Dividend Yield
  • HCTI N/A
  • VRAX N/A
  • EPS Growth
  • HCTI N/A
  • VRAX N/A
  • EPS
  • HCTI N/A
  • VRAX N/A
  • Revenue
  • HCTI $16,565,999.00
  • VRAX $84,872.00
  • Revenue This Year
  • HCTI $88.31
  • VRAX $5,169.18
  • Revenue Next Year
  • HCTI N/A
  • VRAX $66.97
  • P/E Ratio
  • HCTI N/A
  • VRAX N/A
  • Revenue Growth
  • HCTI N/A
  • VRAX 7.03
  • 52 Week Low
  • HCTI $0.29
  • VRAX $0.60
  • 52 Week High
  • HCTI $4.24
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • HCTI 49.04
  • VRAX 42.43
  • Support Level
  • HCTI $0.76
  • VRAX $1.51
  • Resistance Level
  • HCTI $0.99
  • VRAX $1.73
  • Average True Range (ATR)
  • HCTI 0.18
  • VRAX 0.13
  • MACD
  • HCTI 0.00
  • VRAX -0.02
  • Stochastic Oscillator
  • HCTI 26.28
  • VRAX 28.85

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments which are Software Services, Managed Services, and Support and Platform Services.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: